3164 related articles for article (PubMed ID: 22888997)
1. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
[TBL] [Abstract][Full Text] [Related]
2. High-Resolution Mass Spectrometry for Untargeted Drug Screening.
Wu AH; Colby J
Methods Mol Biol; 2016; 1383():153-66. PubMed ID: 26660184
[TBL] [Abstract][Full Text] [Related]
3. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.
Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR
Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923
[TBL] [Abstract][Full Text] [Related]
4. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
[TBL] [Abstract][Full Text] [Related]
5. Comparison of GC/MS and LC/MS methods for the analysis of propofol and its metabolites in urine.
Lee SY; Park NH; Jeong EK; Wi JW; Kim CJ; Kim JY; In MK; Hong J
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 900():1-10. PubMed ID: 22672847
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatography-quadrupole-time-of-flight mass spectrometry screening procedure for urine samples in forensic casework compared to gas chromatography-mass spectrometry.
Fels H; Dame T; Sachs H; Musshoff F
Drug Test Anal; 2017 May; 9(5):824-830. PubMed ID: 27373549
[TBL] [Abstract][Full Text] [Related]
7. General unknown screening in hair by liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
Broecker S; Herre S; Pragst F
Forensic Sci Int; 2012 May; 218(1-3):68-81. PubMed ID: 22036310
[TBL] [Abstract][Full Text] [Related]
8. Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography-tandem mass spectrometry, gas chromatography-mass spectrometry, and immunoassay methods.
Eichhorst J; Etter M; Lepage J; Lehotay DC
Clin Biochem; 2004 Mar; 37(3):175-83. PubMed ID: 14972638
[TBL] [Abstract][Full Text] [Related]
9. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296
[TBL] [Abstract][Full Text] [Related]
10. LC-MS (/MS) in clinical toxicology screening methods.
Viette V; Hochstrasser D; Fathi M
Chimia (Aarau); 2012; 66(5):339-42. PubMed ID: 22867548
[TBL] [Abstract][Full Text] [Related]
11. An LC-MS screening method with library identification for the detection of steroids in dietary supplements.
Becue I; Van Poucke C; Van Peteghem C
J Mass Spectrom; 2011 Mar; 46(3):327-35. PubMed ID: 21394849
[TBL] [Abstract][Full Text] [Related]
12. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
[TBL] [Abstract][Full Text] [Related]
13. Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology.
Maurer HH
Ther Drug Monit; 2010 Jun; 32(3):324-7. PubMed ID: 20418802
[TBL] [Abstract][Full Text] [Related]
14. LC-MS vs. GC-MS, online extraction systems, advantages of technology for drug screening assays.
Marquet P
Methods Mol Biol; 2012; 902():15-27. PubMed ID: 22767104
[TBL] [Abstract][Full Text] [Related]
15. Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control.
Maurer HH
Clin Chem Lab Med; 2004; 42(11):1310-24. PubMed ID: 15576292
[TBL] [Abstract][Full Text] [Related]
16. Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry.
Pozo OJ; Van Thuyne W; Deventer K; Van Eenoo P; Delbeke FT
J Mass Spectrom; 2008 Mar; 43(3):394-408. PubMed ID: 18035854
[TBL] [Abstract][Full Text] [Related]
17. Power of Orbitrap-based LC-high resolution-MS/MS for comprehensive drug testing in urine with or without conjugate cleavage or using dried urine spots after on-spot cleavage in comparison to established LC-MS
Michely JA; Meyer MR; Maurer HH
Drug Test Anal; 2018 Jan; 10(1):158-163. PubMed ID: 28755512
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of low- versus high-resolution liquid chromatography-mass spectrometric strategies for measuring perfluorinated contaminants in fish.
Kadar H; Veyrand B; Antignac JP; Durand S; Monteau F; Le Bizec B
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2011 Sep; 28(9):1261-73. PubMed ID: 21707268
[TBL] [Abstract][Full Text] [Related]
19. Combined use of liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) and high performance liquid chromatography with photodiode array detector (HPLC-DAD) in systematic toxicological analysis.
Broecker S; Pragst F; Bakdash A; Herre S; Tsokos M
Forensic Sci Int; 2011 Oct; 212(1-3):215-26. PubMed ID: 21764531
[TBL] [Abstract][Full Text] [Related]
20. Determination of estrogens and progestogens by mass spectrometric techniques (GC/MS, LC/MS and LC/MS/MS).
Díaz-Cruz MS; López de Alda MJ; López R; Barceló D
J Mass Spectrom; 2003 Sep; 38(9):917-23. PubMed ID: 14505318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
